A 14-gene gemcitabine resistance gene signature is significantly associated with the prognosis of pancreatic cancer patients
Abstract To identify a gemcitabine resistance-associated gene signature for risk stratification and prognosis prediction in pancreatic cancer. Pearson correlation analysis was performed with gemcitabine half maximal inhibitory concentration (IC50) data of 17 primary pancreatic cancer lines from Geno...
Guardado en:
Autores principales: | Xing Wei, Xiaochong Zhou, Yun Zhao, Yang He, Zhen Weng, Chunfang Xu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e70d554dfc1c445f9c91725dcebfa00f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
por: Ru Chen, et al.
Publicado: (2017) -
Antitumor effect of gemcitabine-loaded albumin nanoparticle on gemcitabine-resistant pancreatic cancer induced by low hENT1 expression
por: Guo ZY, et al.
Publicado: (2018) -
A Newly Defined Pyroptosis-Related Gene Signature for the Prognosis of Bladder Cancer
por: Chen W, et al.
Publicado: (2021) -
Identification of an Autophagy-Related Gene Signature for the Prediction of Prognosis in Early-Stage Colorectal Cancer
por: Xu-tao Lin, et al.
Publicado: (2021) -
OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma
por: Jinsheng Ding, et al.
Publicado: (2021)